ARVN vs BIIB: Which Stock is Better?

Side-by-side comparison of Arvinas Inc and Biogen Inc in 2026

Comparison Updated:

ARVN

Arvinas Inc

$8.98

BIIB

Biogen Inc

$196.00

Key Metrics Comparison

MetricARVNBIIBWinner
Market Cap$579.40M$28.94BBIIB
P/E RatioN/A21.10BIIB
EPS (TTM)$N/A$9.29BIIB
Revenue Growth-0.9%0.0%BIIB
Gross Margin134.5%78.7%ARVN

Analyze ARVN

Full quant analysis

Analyze BIIB

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is ARVN or BIIB a better investment?

Comparing ARVN and BIIB: Arvinas Inc has a market cap of $579.40M while Biogen Inc has $28.94B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between ARVN and BIIB?

ARVN (Arvinas Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: ARVN or BIIB?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: ARVN or BIIB?

BIIB has higher revenue growth at 0.0% vs -0.9% for ARVN.

Which company is more profitable: ARVN or BIIB?

Arvinas Inc (ARVN) has higher gross margins at 134.5% compared to 78.7% for BIIB.

Which is the larger company: ARVN or BIIB?

Biogen Inc (BIIB) is larger with a market cap of $28.94B compared to $579.40M for ARVN.

Should I buy ARVN or BIIB in 2026?

Both ARVN and BIIB have investment merit. ARVN trades at $8.98 while BIIB trades at $196.00. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between ARVN and BIIB stock?

Key differences: Market Cap ($579.40M vs $28.94B), P/E Ratio (N/A vs 21.1x), Revenue Growth (-0.9% vs 0.0%), Gross Margin (134.5% vs 78.7%).

Popular Stock Comparisons